Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
4.290
-0.460 (-9.68%)
At close: Jun 18, 2026, 4:00 PM EDT
4.212
-0.078 (-1.83%)
After-hours: Jun 18, 2026, 8:00 PM EDT

Regentis Biomaterials Statistics

Total Valuation

RGNT has a market cap or net worth of $22.22 million. The enterprise value is $16.04 million.

Market Cap22.22M
Enterprise Value 16.04M

Important Dates

The next estimated earnings date is Saturday, August 8, 2026, after market close.

Earnings Date Aug 8, 2026
Ex-Dividend Date n/a

Share Statistics

RGNT has 5.18 million shares outstanding. The number of shares has increased by 249.42% in one year.

Current Share Class 5.18M
Shares Outstanding 5.18M
Shares Change (YoY) +249.42%
Shares Change (QoQ) +498.83%
Owned by Insiders (%) 2.48%
Owned by Institutions (%) 12.98%
Float 2.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.68
P/TBV Ratio 4.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.25.

Current Ratio 2.65
Quick Ratio 2.65
Debt / Equity 0.25
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -88.20

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -107.53%
Return on Invested Capital (ROIC) -178.48%
Return on Capital Employed (ROCE) -146.88%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.96M
Employee Count 7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 2.68
200-Day Moving Average n/a
Relative Strength Index (RSI) 55.10
Average Volume (20 Days) 15,435,009

Short Selling Information

The latest short interest is 25,580, so 0.49% of the outstanding shares have been sold short.

Short Interest 25,580
Short Previous Month n/a
Short % of Shares Out 0.49%
Short % of Float 0.91%
Short Ratio (days to cover) 0.88

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -6.97M
Pretax Income -13.65M
Net Income -13.69M
EBITDA n/a
EBIT -6.97M
Earnings Per Share (EPS) -$24.16
Full Income Statement

Balance Sheet

The company has $7.38 million in cash and $1.20 million in debt, with a net cash position of $6.18 million or $1.19 per share.

Cash & Cash Equivalents 7.38M
Total Debt 1.20M
Net Cash 6.18M
Net Cash Per Share $1.19
Equity (Book Value) 4.74M
Book Value Per Share 0.92
Working Capital 4.74M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.38M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing 300,000
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RGNT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -249.42%
Shareholder Yield -249.42%
Earnings Yield -61.62%
FCF Yield n/a

Analyst Forecast

The average price target for RGNT is $10.00, which is 133.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 133.10%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2